Omission of day-11 MTX, in combination with tacrolimus, is not associated with increased risk of acute graft-versus-host disease after allo-BMT

Bone Marrow Transplant. 2013 Feb;48(2):307-9. doi: 10.1038/bmt.2012.128. Epub 2012 Jul 2.

Authors

A Honda, K Kakihana, J Aoki, T Kobayashi, N Doki, H Sakamaki, K Ohashi

PMID: 22751000
DOI: 10.1038/bmt.2012.128

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Bone Marrow Transplantation / adverse effects*
Bone Marrow Transplantation / methods*
Female
Graft vs Host Disease / etiology*
Graft vs Host Disease / prevention & control*
Humans
Immunosuppressive Agents / administration & dosage*
Male
Methotrexate / administration & dosage*
Middle Aged
Retrospective Studies
Risk Factors
Tacrolimus / administration & dosage*
Young Adult

Substances

Immunosuppressive Agents
Tacrolimus
Methotrexate